NDC 33342-176

Pioglitazole and metformin hydrochloride

Pioglitazole And Metformin Hydrochloride

Pioglitazole and metformin hydrochloride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Pioglitazone Hydrochloride; Metformin Hydrochloride.

• Product ID: 33342-176_219d99c8-1d70-42c8-a9e4-76b972c4d5b5
• NDC: 33342-176
• Product Type: Human Prescription Drug
• Proprietary Name: Pioglitazole and metformin hydrochloride
• Generic Name: Pioglitazole And Metformin Hydrochloride
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2015-11-06
• Marketing Category: ANDA / ANDA
• Application Number: ANDA204802
• Labeler Name: Macleods Pharmaceuticals Limited
• Substance Name: PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
• Active Ingredient Strength: 15 mg/1; mg/1
• Pharm Classes: Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Biguanide [EPC],Biguanides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 33342-176-09

60 TABLET in 1 BOTTLE (33342-176-09)

• Marketing Start Date: 2015-11-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 33342-176-57 [33342017657]

Pioglitazole and metformin hydrochloride TABLET

• Marketing Category: ANDA
• Application Number: ANDA204802
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-11-06

NDC 33342-176-12 [33342017612]

Pioglitazole and metformin hydrochloride TABLET

• Marketing Category: ANDA
• Application Number: ANDA204802
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-11-06

NDC 33342-176-44 [33342017644]

Pioglitazole and metformin hydrochloride TABLET

• Marketing Category: ANDA
• Application Number: ANDA204802
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-11-06

NDC 33342-176-09 [33342017609]

Pioglitazole and metformin hydrochloride TABLET

• Marketing Category: ANDA
• Application Number: ANDA204802
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-11-06

NDC 33342-176-11 [33342017611]

Pioglitazole and metformin hydrochloride TABLET

• Marketing Category: ANDA
• Application Number: ANDA204802
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-11-06

Drug Details

Active Ingredients

Ingredient	Strength
PIOGLITAZONE HYDROCHLORIDE	15 mg/1

OpenFDA Data

• SPL SET ID: 5ff2cd9e-a579-48f5-845f-c37a68372a34
• Manufacturer:
  • Macleods Pharmaceuticals Limited
• UNII:
  • JQT35NPK6C
  • 786Z46389E
• RxNorm Concept Unique ID - RxCUI:
  • 861783
  • 861822
• UPC Code:
  • 0333342176097
  • 0333342176110
  • 0333342176448
  • 0333342177445

Pharmacological Class

• Peroxisome Proliferator-activated Receptor Activity [MoA]
• PPAR alpha [CS]
• PPAR gamma [CS]
• Thiazolidinedione [EPC]
• Thiazolidinediones [CS]
• Peroxisome Proliferator Receptor alpha Agonist [EPC]
• Peroxisome Proliferator Receptor gamma Agonist [EPC]
• Biguanide [EPC]
• Biguanides [CS]

Medicade Reported Pricing

33342017657 PIOGLITAZONE-METFORMIN 15-500

Pricing Unit: EA | Drug Type:

33342017609 PIOGLITAZONE-METFORMIN 15-500

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Pioglitazole and metformin hydrochloride" or generic name "Pioglitazole And Metformin Hydrochloride"

NDC	Brand Name	Generic Name
33342-176	Pioglitazole and metformin hydrochloride	Pioglitazole and metformin hydrochloride
33342-177	Pioglitazole and metformin hydrochloride	Pioglitazole and metformin hydrochloride